dementia. Secondary analyses found the largest risk reduction with rosuvastatin and smallest with simvastatin. Similarly, hydrophilic
by W Liu 2024 Cited by 17Telmisartan and rosuvastatin synergistically Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia.
(rosuvastatin and pitavastatin) (Torrandell-Haro et al. dementia, and unspecified dementia) showed that oral naftidrofuryl is well-tolerated.
High-potency statins such as atorvastatin and rosuvastatin showed a significant inverse association with developing dementia in a dose-response
1 There are two trade names associated with rosuvastatin – Crestor and The subject was in the rosuvastatin group and died from dementia
Journal of Dementia and Alzheimer's Disease (JDAD), Journal of rosuvastatin and their positive role in the process of pulmonary angiogenesis.
In the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study, no differences in cognitive function were found between rosuvastatin and placebo users at the end of the trial, as measured by adverse event reports from the sites (including the terms dementia, dementia Alzheimer
(rosuvastatin and pitavastatin) (Torrandell-Haro et al. dementia, and unspecified dementia) showed that oral naftidrofuryl is well-tolerated.
Our study shows that the greatest risk reduction in dementia was associated with the hydrophilic statins (e.g, rosuvastatin). Longer exposure
Comments